Workshop: Pharmaceutical Industry

How will you adapt to the new realities of the Pharmaceutical Industry?



Level(s): S / U  
The pharmaceutical industry is undergoing unprecedented transformation. From heavy cost containment from payers, to the infamous “patent cliff”, there are a number of converging forces that drive down value creation in Pharma. Maintaining the ongoing commercial operations, as they have been managed over the last decades, is economically unsustainable. Pharmaceutical companies must adapt to a new environment, which is more demanding than ever before.  They must adopt lower cost models across the whole value chain and improve productivity and efficiency in their commercial approaches. This Commercial Excellence workshop will enable you to reconsider and redesign the way you operate your commercial model, from marketing to medical-marketing and to sales, in order to develop a sustainable competitive advantage for your company. 
“Commercial” Effectiveness in Pharma: Think beyond Sales Force Effectiveness  training info










Level(s): M / U  
Getting Ready for Your Future Role as Senior Manager in the Pharmaceutical Industry  training info


Level(s): M / U  
The pharmaceutical industry is undergoing unprecedented transformation due to number of major changes in the healthcare environment. Patents are expiring one after another. Authorities around the world increase pressure and deploy broad measures to contain the growth of healthcare costs. The customer landscape is becoming more and more complex, often centralized and heavily networked. Payers, whether public or private, hospital networks, buying groups and the like, want more results and more value, preferably at discounted prices! In other words, they want “Value for Money”.This new reality inevitably increases the complexity of selling, with the implementation of things like health technology assessment agencies, formulary committees, clinical committees, buying clusters, practice-based commissioning and so on. As buying complexity has increased, so must selling sophistication to align with that. This workshop will review and discuss the changes that Pharma must make in order to accommodate the more organized buyers and overcome the new selling barriers it is facing.   
Institutional Selling: Selling to National Health Insurance Systems, Hospital Networks, Buying Groups and Insurers  training info






Level(s): S / U  
We all know that we are living in a world that is more global than ever before, thanks to the internet and easy communications. However, most pharmaceutical companies have established regional organisations to coordinate and oversee operations taking place in groups of countries. For a large number of reasons, regional marketing activities may deviate to small or high degree from the global marketing strategies determined by the headquarters. There are good and valid reasons from that, for instance: different portfolios or product life-cycle, different regulatory environment, competitors, medical practices, pricing and distribution channels. For efficiency and productivity reasons, companies try to regionalise their marketing. This represents a fair balance between truly global and purely local marketing but poses number of coordination challenges, which this workshop will review, analyse and propose solutions.
Managing Brands Regionally and Selling Locally: Efficient Marketing Matrix and Processes in Pharma training info


Level(s): S / U  
Patents of blockbuster drugs expire one after another, R&D pipelines are dry, social security deficits explode and push for more healthcare cost containment and generics thrive. Clearly, the growth engine in the Western markets is stalling. Big Pharma is undertaking a dramatic shift in terms of where it can turn to resume growth and secure profitability. As from 2009, it is predicted that “Pharmerging” (or BRIC+TKM) will be responsible for more than 50% of the growth in the global pharmaceutical markets. Except for a few early believers, it is only now that most multinational pharmaceutical companies are waking up and trying to develop and deploy plans to capture a share of the untapped potential in the emerging markets. This workshop will review the alternative strategic options that Big Pharma should consider for the emerging markets and the impacts they will have on your operational model. 
Managing Emerging Markets: Strategic Decisions, Operational Options  training info






Level(s): S / U  

The pharmaceutical industry has reached maturity when it comes to the classical blockbuster model and is fast moving into highly specialized fields like oncology, diabetes and orphan diseases. At the same time, the traditional “size sells” paradigm is no longer working. Medical information and education are key opportunities to succeed in the new healthcare environment and therapeutic areas, ensuring customer engagement, trust and higher revenues.


More than ever before, your customers need medical information and education. Budgets are constantly increasing and skilled resources are hard to obtain. How do you select and manage the right programmes within the tight regulatory framework? How do you assess customer engagement afterwards? What is the role of new channels?


This workshop highlights the new medical interaction and engagement models in-depth.


Medical Affairs and Medical Education: Key to Success training info


Level(s): M / U  
Operational Excellence in Pharma Supply Chain Management  training info








Mass market medications are traditionally associated with high proportions of non-responders, which are a source clinical inefficacy, adverse drug reactions and poor resources utilization. With the advent of pharmacogenomics, diagnostic biomarkers allow pointing to the most appropriate treatments i.e.  targeted drugs. This paves the way to so-called Personalized Medicine. For patients, physicians and payers, such personalized medicine offers clear clinical and economic advantages by making more predictable outcomes and enhancing efficacy through prior identification of responders.  While personalized medicine offers the potential to improve well-established medical practices, the concept presents a major challenge to the pharmaceutical industry. This workshop will guide you through the challenges posed to our industry by personalized medicine and the changes it will trigger on our business models, from Drug Development to Commercialization, including Market Access
Personalized Medicine: What it means for Pharma  training info




Level(s): M / U  
The pharmaceutical industry is undergoing unprecedented transformation due to the tremendous changes in its environment. New technologies, cost pressure, consolidation, downsizing and reorganisation, need for new competences in Health Economics and Outcomes, Market Access and Advocacy, Medical Marketing, Relationship Management, Key Account Management, Outsourcing Management, just to name a few new Pharma realities.As we develop new strategies to address the issues and opportunities of this changing environment, our needs in terms of people become increasingly difficult to fulfil. The good news is there is a lot of value HR can add to the business by aligning talent and performance management systems to support the strategy. MCE's Pharma Skills & Talent Management workshop will increase your ability to master it, thus enabling superior and sustained performance of your organisation.
Securing Pharma Skills & Talent Management for Superior and Sustained Performance  training info


Level(s): M / U  
The pharmaceutical industry is in turmoil and undergoing unprecedented transformation. In the era of the highly profitable mass-market blockbusters, Big Pharma could afford lots of inefficiencies along its value chain. These times are gone and pressure on costs is increasingly intense in the pharmaceutical world.Traditionally, pharmaceutical companies were vertically-integrated fully. But, as we are in pervasive search for efficiency and savings, the industry is externalising many of its functions and “disintegrating” its vertical model.In this highly interactive workshop, we will focus on moving from a buyer-seller relationship, to a strategic partner relationship with key suppliers and vendors. This involves recognizing and applying good practices when engaging with and managing suppliers, drawing on a variety of strategic approaches and complying with GMPs and applicable international rules and regulations.
Supply Chain Management in Pharma: Strategic Sourcing and Supply Chain Governance  training info






Level(s): M / U  

The seismic shift in the healthcare market requires transformational innovation from marketing, including new value-added services, taking full responsibility for marketing ROI, understanding integrated multichannel campaign management and creating stronger links between Marketing, Sales, Medical Affairs and the customer.


 

This workshop gives you a solid overview of the latest trends in healthcare and key tools to address these. We focus on the practical application of these concepts, so that you will have an action-oriented toolkit with which you can begin to make immediate improvements in your strategy and its execution. Starting from customer/consumer motivations, you will explore the role of product management and marketing organisational realignment, and define the critical differences between marketing and sales, while deepening your understanding of the strategic mission of both a business unit and the company as a whole. The workshop will also address the strategy, intelligence and implementation of marketing products and services that are often truly "life or death" solutions.

Value-based Marketing in the Pharmaceutical Industry training info




 
Search by keyword
Search by location

How will you adapt to the new realities of the Pharmaceutical Industry training info request training info request
Need more info?
• Leave your phone number here and we'll call you back.
• Send us an email
• Call us: +32 2 543 21 20


   
AmaNet AmaNet Latin America AmaNet Asia CMC Canada MCE Europe, Middle East, Africa